Artículos

Paliperidone extended-release in schizoaffective disorder / Carla M. Canuso en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 487-495 Título : Paliperidone extended-release in schizoaffective disorder : A randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers Tipo de documento: texto impreso Autores: Carla M. Canuso, Autor ; Nina R. Schooler, Autor ; Jennifer Carothers, Autor Fecha de publicación: 2022 Artículo en la página: pp. 487-495 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno esquizoafectivo, Paliperidona ER, Antipsicóticos, Antidepresivos, Estabilizadores del estado de ánimo Resumen: This 6-week, double-blind, placebo-controlled study evaluated paliperidone extended-release (ER) as both monotherapy and adjunctive therapy to mood stabilizers and/or antidepressants (MS/ADs) for schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=29420 [artículo] Paliperidone extended-release in schizoaffective disorder : A randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers [texto impreso] / Carla M. Canuso, Autor ; Nina R. Schooler, Autor ; Jennifer Carothers, Autor . - 2022 . - pp. 487-495. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 487-495 Palabras clave: Trastorno esquizoafectivo, Paliperidona ER, Antipsicóticos, Antidepresivos, Estabilizadores del estado de ánimo Resumen: This 6-week, double-blind, placebo-controlled study evaluated paliperidone extended-release (ER) as both monotherapy and adjunctive therapy to mood stabilizers and/or antidepressants (MS/ADs) for schizoaffective disorder. Link: ./index.php?lvl=notice_display&id=29420

Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine Correlations to clinical outcome and hva, 5-hiaa, and mhpg in csf / Georg Nikisch en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 496-503 Título : Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine Correlations to clinical outcome and hva, 5-hiaa, and mhpg in csf Tipo de documento: texto impreso Autores: Georg Nikisch, Autor ; Pierre Baumann, Autor ; Georg Wiedemann, Autor Fecha de publicación: 2022 Artículo en la página: pp. 496-503 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, Quetiapina, Norquetiapina, Plasma, LCR, Metabolitos de monoamina Resumen: This study investigated concentrations of quetiapine and norquetiapine in plasma and cerebrospinal fluid (CSF) in 22 schizophrenic patients after 4-week treatment with quetiapine (600 mg/d), which was preceded by a 3-week washout period. Blood and CSF samples were obtained on days 1 and 28, and CSF levels of homovanillic acid (HVA),... Link: ./index.php?lvl=notice_display&id=29421 [artículo] Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine Correlations to clinical outcome and hva, 5-hiaa, and mhpg in csf [texto impreso] / Georg Nikisch, Autor ; Pierre Baumann, Autor ; Georg Wiedemann, Autor . - 2022 . - pp. 496-503. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 496-503 Palabras clave: Esquizofrenia, Quetiapina, Norquetiapina, Plasma, LCR, Metabolitos de monoamina Resumen: This study investigated concentrations of quetiapine and norquetiapine in plasma and cerebrospinal fluid (CSF) in 22 schizophrenic patients after 4-week treatment with quetiapine (600 mg/d), which was preceded by a 3-week washout period. Blood and CSF samples were obtained on days 1 and 28, and CSF levels of homovanillic acid (HVA),... Link: ./index.php?lvl=notice_display&id=29421

Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers / Jesús Novalbos en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 504-511 Título : Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers Tipo de documento: texto impreso Autores: Jesús Novalbos, Autor ; Rosario López Rodríguez, Autor ; Manuel Román, Autor Fecha de publicación: 2022 Artículo en la página: pp. 504-511 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: CYP2D6, Risperidona, 9-hidroxirisperidona, Farmacogenética, Farmacocinética, Voluntarios sanos Resumen: The objective of this study was to analyze the relationship between CYP2D6 genotype and pharmacokinetics and pharmacodynamics of risperidone. Seventy-one healthy volunteers (36 women and 35 men) received a 1-mg single oral dose of risperidone. Six major CYP2D6 polymorphisms (CYP2D6*3, *4, *5, *6, *7, and *9) and the duplication were detected. Link: ./index.php?lvl=notice_display&id=29422 [artículo] Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers [texto impreso] / Jesús Novalbos, Autor ; Rosario López Rodríguez, Autor ; Manuel Román, Autor . - 2022 . - pp. 504-511. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 504-511 Palabras clave: CYP2D6, Risperidona, 9-hidroxirisperidona, Farmacogenética, Farmacocinética, Voluntarios sanos Resumen: The objective of this study was to analyze the relationship between CYP2D6 genotype and pharmacokinetics and pharmacodynamics of risperidone. Seventy-one healthy volunteers (36 women and 35 men) received a 1-mg single oral dose of risperidone. Six major CYP2D6 polymorphisms (CYP2D6*3, *4, *5, *6, *7, and *9) and the duplication were detected. Link: ./index.php?lvl=notice_display&id=29422

C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients / Hui Hua Chang en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 512-517 Título : C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients Tipo de documento: texto impreso Autores: Hui Hua Chang, Autor ; Po Wu Gean, Autor ; Chen Hsi Chou, Autor Fecha de publicación: 2022 Artículo en la página: pp. 512-517 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: GNB3, Valproato, Trastorno bipolar, Alteración metabólica, Leptina, IMC Resumen: Valproate (VPA) is a mood stabilizer for treating patients with bipolar disorder (BD). It may cause metabolic abnormalities in certain bipolar patients. However, the genetic factors that influence the susceptibility remain unclear. Genetic polymorphism of the G-protein β3 subunit (GNB3) is reported to be associated with metabolic phenotypes. Link: ./index.php?lvl=notice_display&id=29423 [artículo] C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients [texto impreso] / Hui Hua Chang, Autor ; Po Wu Gean, Autor ; Chen Hsi Chou, Autor . - 2022 . - pp. 512-517. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 512-517 Palabras clave: GNB3, Valproato, Trastorno bipolar, Alteración metabólica, Leptina, IMC Resumen: Valproate (VPA) is a mood stabilizer for treating patients with bipolar disorder (BD). It may cause metabolic abnormalities in certain bipolar patients. However, the genetic factors that influence the susceptibility remain unclear. Genetic polymorphism of the G-protein β3 subunit (GNB3) is reported to be associated with metabolic phenotypes. Link: ./index.php?lvl=notice_display&id=29423

A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia / Ching Hua Lin en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 518-525 Título : A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia Tipo de documento: texto impreso Autores: Ching Hua Lin, Autor ; Chao Chan Kuo, Autor ; Li Shiu Chou, Autor Fecha de publicación: 2022 Artículo en la página: pp. 518-525 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Combinación de fármacos antipsicóticos, Esquizofrenia, Haloperidol, Risperidona Resumen: Monotherapy is recommended for schizophrenia treatment, but the risk-benefit issue of antipsychotic drug combination (except for clozapine) remains unclear. Risperidone, an atypical antipsychotic drug, has a lower incidence of extrapyramidal syndrome but higher risks of prolactinemia and metabolic syndrome than haloperidol, a typical agent. Link: ./index.php?lvl=notice_display&id=29424 [artículo] A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia [texto impreso] / Ching Hua Lin, Autor ; Chao Chan Kuo, Autor ; Li Shiu Chou, Autor . - 2022 . - pp. 518-525. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 518-525 Palabras clave: Combinación de fármacos antipsicóticos, Esquizofrenia, Haloperidol, Risperidona Resumen: Monotherapy is recommended for schizophrenia treatment, but the risk-benefit issue of antipsychotic drug combination (except for clozapine) remains unclear. Risperidone, an atypical antipsychotic drug, has a lower incidence of extrapyramidal syndrome but higher risks of prolactinemia and metabolic syndrome than haloperidol, a typical agent. Link: ./index.php?lvl=notice_display&id=29424

Antipsychotic drug use and the risk of venous thromboembolism in elderly patients / Bart C. Kleijer en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 526-530 Título : Antipsychotic drug use and the risk of venous thromboembolism in elderly patients Tipo de documento: texto impreso Autores: Bart C. Kleijer, Autor ; Eibert R. Heerdink, Autor ; Toine C.G. Egberts, Autor Fecha de publicación: 2022 Artículo en la página: pp. 526-530 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anciano, Antipsicóticos, Trombosis venosa, Factores de riesgo, Efectos adversos Resumen: Our aim was to investigate the relationship between exposure to antipsychotic drugs and the risk of venous thromboembolism (VTE) in elderly patients. Link: ./index.php?lvl=notice_display&id=29425 [artículo] Antipsychotic drug use and the risk of venous thromboembolism in elderly patients [texto impreso] / Bart C. Kleijer, Autor ; Eibert R. Heerdink, Autor ; Toine C.G. Egberts, Autor . - 2022 . - pp. 526-530. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 526-530 Palabras clave: Anciano, Antipsicóticos, Trombosis venosa, Factores de riesgo, Efectos adversos Resumen: Our aim was to investigate the relationship between exposure to antipsychotic drugs and the risk of venous thromboembolism (VTE) in elderly patients. Link: ./index.php?lvl=notice_display&id=29425

Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia / Diego Novick en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 531-540 Título : Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia : Thirty-six-month results from the european schizophrenia outpatient health outcomes study Tipo de documento: texto impreso Autores: Diego Novick, Autor ; Josep Maria Haro, Autor ; Jordan Bertsch, Autor Fecha de publicación: 2022 Artículo en la página: pp. 531-540 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, TD, EPS, Tratamiento antipsicótico Resumen: The incidence of treatment-emergent extrapyramidal symptoms (EPSs) and tardive dyskinesia (TD) in schizophrenic patients, and the clinical characteristics associated with an increased risk of developing EPSs and TD were examined. Patients (N = 7728) in the 3-year, prospective, observational Schizophrenia Outpatient Health Outcomes study were examined according to baseline antipsychotic drug exposure. Link: ./index.php?lvl=notice_display&id=29426 [artículo] Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia : Thirty-six-month results from the european schizophrenia outpatient health outcomes study [texto impreso] / Diego Novick, Autor ; Josep Maria Haro, Autor ; Jordan Bertsch, Autor . - 2022 . - pp. 531-540. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 531-540 Palabras clave: Esquizofrenia, TD, EPS, Tratamiento antipsicótico Resumen: The incidence of treatment-emergent extrapyramidal symptoms (EPSs) and tardive dyskinesia (TD) in schizophrenic patients, and the clinical characteristics associated with an increased risk of developing EPSs and TD were examined. Patients (N = 7728) in the 3-year, prospective, observational Schizophrenia Outpatient Health Outcomes study were examined according to baseline antipsychotic drug exposure. Link: ./index.php?lvl=notice_display&id=29426

Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia / Louise Dulude en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 541-548 Título : Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia Tipo de documento: texto impreso Autores: Louise Dulude, Autor ; Alain Labelle, Autor ; Verner J. Knott, Autor Fecha de publicación: 2022 Artículo en la página: pp. 541-548 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Nicotina, Esquizofrenia, Potenciales relacionados con eventos, MMN, Negatividad de desajuste, Tabaco, Memoria sensorial Resumen: Patients with schizophrenia have a high rate of cigarette smoking and also exhibit profound deficits in sensory processing, which may in part be ameliorated by the acute actions of smoke-inhaled nicotine. The mismatch negativity (MMN), a preattentive event-related potential index of auditory sensory memory, is diminished in schizophrenia. Link: ./index.php?lvl=notice_display&id=29427 [artículo] Acute nicotine alteration of sensory memory impairment in smokers with schizophrenia [texto impreso] / Louise Dulude, Autor ; Alain Labelle, Autor ; Verner J. Knott, Autor . - 2022 . - pp. 541-548. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 541-548 Palabras clave: Nicotina, Esquizofrenia, Potenciales relacionados con eventos, MMN, Negatividad de desajuste, Tabaco, Memoria sensorial Resumen: Patients with schizophrenia have a high rate of cigarette smoking and also exhibit profound deficits in sensory processing, which may in part be ameliorated by the acute actions of smoke-inhaled nicotine. The mismatch negativity (MMN), a preattentive event-related potential index of auditory sensory memory, is diminished in schizophrenia. Link: ./index.php?lvl=notice_display&id=29427

A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder / Joseph Biederman en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 549-553 Título : A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder Tipo de documento: texto impreso Autores: Joseph Biederman, Autor ; Eric Mick, Autor ; Craig B. H. Surman, Autor Fecha de publicación: 2022 Artículo en la página: pp. 549-553 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Adulto, TDAH, Estimulante, Ensayo aleatorizado, Metilfenidato, Psicofarmacología Resumen: We conducted a 3-phase, double-blind, placebo-controlled, parallel study design of osmotic-release oral system (OROS)-methylphenidate (MPH) in adults (19-60 years of age) with attention deficit/hyperactivity disorder as classified by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Link: ./index.php?lvl=notice_display&id=29428 [artículo] A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder [texto impreso] / Joseph Biederman, Autor ; Eric Mick, Autor ; Craig B. H. Surman, Autor . - 2022 . - pp. 549-553. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 549-553 Palabras clave: Adulto, TDAH, Estimulante, Ensayo aleatorizado, Metilfenidato, Psicofarmacología Resumen: We conducted a 3-phase, double-blind, placebo-controlled, parallel study design of osmotic-release oral system (OROS)-methylphenidate (MPH) in adults (19-60 years of age) with attention deficit/hyperactivity disorder as classified by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Link: ./index.php?lvl=notice_display&id=29428

Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder / David Pierce en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 554-564 Título : Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder Tipo de documento: texto impreso Autores: David Pierce, Autor ; Alain Katic, Autor ; Mary Buckwalter, Autor Fecha de publicación: 2022 Artículo en la página: pp. 554-564 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Farmacocinética, Sistema transdérmico de metilfenidato, Metilfenidato del sistema oral de liberación osmótica, Trastorno por déficit de atención con hiperactividad Resumen: This was a 1-month, multicenter, open-label, randomized study to determine single- and multiple-dose pharmacokinetics of d,l-methylphenidate (MPH) after MPH transdermal system (MTS) and osmotic-release oral system MPH (OROS MPH) dosing in children (6-12 years) and adolescents (13-17 years) who had a diagnosis of attention deficit hyperactivity disorder. Link: ./index.php?lvl=notice_display&id=29429 [artículo] Single- and multiple-dose pharmacokinetics of methylphenidate administered as methylphenidate transdermal system or osmotic-release oral system methylphenidate to children and adolescents with attention deficit hyperactivity disorder [texto impreso] / David Pierce, Autor ; Alain Katic, Autor ; Mary Buckwalter, Autor . - 2022 . - pp. 554-564. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 554-564 Palabras clave: Farmacocinética, Sistema transdérmico de metilfenidato, Metilfenidato del sistema oral de liberación osmótica, Trastorno por déficit de atención con hiperactividad Resumen: This was a 1-month, multicenter, open-label, randomized study to determine single- and multiple-dose pharmacokinetics of d,l-methylphenidate (MPH) after MPH transdermal system (MTS) and osmotic-release oral system MPH (OROS MPH) dosing in children (6-12 years) and adolescents (13-17 years) who had a diagnosis of attention deficit hyperactivity disorder. Link: ./index.php?lvl=notice_display&id=29429

Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis / Martin Lambert en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 565-572 Título : Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis Tipo de documento: texto impreso Autores: Martin Lambert, Autor ; Philippe Conus, Autor ; Sue M. Cotton, Autor Fecha de publicación: 2022 Artículo en la página: pp. 565-572 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Primer episodio de psicosis, Esquizofrenia, Adherencia a la medicación, Predictores, Seguimiento, Adolescentes Resumen: Studies investigating medication adherence in psychosis are limited by the need of a certain degree of medication adherence and the inclusion of mostly multiple-episode patients. By contrast, noninformed consent, epidemiological studies in first-episode psychosis (FEP) allow the assessment of an important subgroup of patients who persistently refuse antipsychotic medication and thereby never receive an adequate antipsychotic trial. Link: ./index.php?lvl=notice_display&id=29430 [artículo] Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis [texto impreso] / Martin Lambert, Autor ; Philippe Conus, Autor ; Sue M. Cotton, Autor . - 2022 . - pp. 565-572. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 565-572 Palabras clave: Primer episodio de psicosis, Esquizofrenia, Adherencia a la medicación, Predictores, Seguimiento, Adolescentes Resumen: Studies investigating medication adherence in psychosis are limited by the need of a certain degree of medication adherence and the inclusion of mostly multiple-episode patients. By contrast, noninformed consent, epidemiological studies in first-episode psychosis (FEP) allow the assessment of an important subgroup of patients who persistently refuse antipsychotic medication and thereby never receive an adequate antipsychotic trial. Link: ./index.php?lvl=notice_display&id=29430

Effects of 2 adenosine antagonists, quercetin and caffeine, on vigilance and mood / Craig A. Olson en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 573-578 Título : Effects of 2 adenosine antagonists, quercetin and caffeine, on vigilance and mood Tipo de documento: texto impreso Autores: Craig A. Olson, Autor ; Jennifer A. Thornton, Autor ; Gina E. Adam, Autor Fecha de publicación: 2022 Artículo en la página: pp. 573-578 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Suplemento dietético, Rendimiento cognitivo, Flavonoide, Estado de alerta, Fatiga Resumen: Quercetin, a phenolic flavonoid found in small quantities in some fruits and vegetables, is an adenosine receptor antagonist in vitro marketed as a dietary supplement for purported caffeine-like effects. A double-blind, placebo-controlled, between-subjects study was conducted to compare the behavioral effects of quercetin to a central adenosine receptor antagonist, caffeine. Link: ./index.php?lvl=notice_display&id=29431 [artículo] Effects of 2 adenosine antagonists, quercetin and caffeine, on vigilance and mood [texto impreso] / Craig A. Olson, Autor ; Jennifer A. Thornton, Autor ; Gina E. Adam, Autor . - 2022 . - pp. 573-578. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 573-578 Palabras clave: Suplemento dietético, Rendimiento cognitivo, Flavonoide, Estado de alerta, Fatiga Resumen: Quercetin, a phenolic flavonoid found in small quantities in some fruits and vegetables, is an adenosine receptor antagonist in vitro marketed as a dietary supplement for purported caffeine-like effects. A double-blind, placebo-controlled, between-subjects study was conducted to compare the behavioral effects of quercetin to a central adenosine receptor antagonist, caffeine. Link: ./index.php?lvl=notice_display&id=29431

Treatment options for bipolar depression / Eduard Vieta i Pascual en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 5 (Octubre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 579-590 Título : Treatment options for bipolar depression : A systematic review of randomized, controlled trials Tipo de documento: texto impreso Autores: Eduard Vieta i Pascual, Autor ; Julie Locklear, Autor ; Oliver Günther, Autor Fecha de publicación: 2022 Artículo en la página: pp. 579-590 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Depresión bipolar, Depresión, Agentes antipsicóticos, Antidepresivos, Estabilizadores del estado de ánimo, Revisión sistemática Resumen: This meta-analysis examined the effectiveness of treatments of bipolar depression. Trials were identified using the MEDLINE, EMBASE, http://www.clinicaltrials.gov, and Cochrane databases (1993 to July 2008). The outcome measures included mean change in Montgomery-Åsberg Depression Rating Scale (MADRS) or Hamilton Depression Rating Scale (HAM-D) total scores, and rates of response and remission. Link: ./index.php?lvl=notice_display&id=29432 [artículo] Treatment options for bipolar depression : A systematic review of randomized, controlled trials [texto impreso] / Eduard Vieta i Pascual, Autor ; Julie Locklear, Autor ; Oliver Günther, Autor . - 2022 . - pp. 579-590. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 5 (Octubre) . - pp. 579-590 Palabras clave: Trastorno bipolar, Depresión bipolar, Depresión, Agentes antipsicóticos, Antidepresivos, Estabilizadores del estado de ánimo, Revisión sistemática Resumen: This meta-analysis examined the effectiveness of treatments of bipolar depression. Trials were identified using the MEDLINE, EMBASE, http://www.clinicaltrials.gov, and Cochrane databases (1993 to July 2008). The outcome measures included mean change in Montgomery-Åsberg Depression Rating Scale (MADRS) or Hamilton Depression Rating Scale (HAM-D) total scores, and rates of response and remission. Link: ./index.php?lvl=notice_display&id=29432